This was the stock's fourth consecutive day of gains.

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research ...

For most investors, how much a stock's price changes over time is important. Not only can it impact your investment portfolio, but it can also help you compare investment results across sectors and ...

FIRDAPSE boosts Catalyst's strong Q1 2025 results, beating forecasts. With 15–20% growth projected, see why analysts rate ...

In 2025, the catalyst bins market is estimated to be valued at approximately USD 39,086.58 million. Looking ahead to ...

This was the stock's second consecutive day of gains.

Catalyst Pharmaceuticals Inc. stock grades by Barron's. View CPRX fundamental and sentiment analysis powered by MarketGrader.

Catalyst Pharmaceuticals reported a robust start to 2025 with earnings per share (EPS) of $0.68, doubling the forecast of $0.34. Revenue reached $141.4 million, surpassing expectations of $131.54 ...

CORAL GABLES, Fla. (AP) — CORAL GABLES, Fla. (AP) — Catalyst Pharmaceutical Partners Inc. (CPRX) on Wednesday reported first-quarter profit of $56.7 million. The Coral Gables, Florida-based company ...

CORAL GABLES, Fla., May 07, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), today reported financial results for the first quarter of 2025 and ...

Commonwealth Equity Services LLC raised its stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 133.1% in the fourth quarter, according to the company in its most recent ...

In its fourth quarter 2024 investor letter, Renaissance Investment Management Small Cap Growth Strategy emphasized stocks such as Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX). Catalyst ...